Industrywide Survey Reveals Centralising Regulatory is Number One Priority for Medtech
March 1, 2023Business Services
BARCELONA, Spain — 28 Feb. 2023 — New research shows a majority of medtech organizations are taking action to advance …
Ascelia Pharma meets major milestone with patient enrollment completion of Phase 3 Study for Orviglance, novel MRI contrast agent for patients with kidney impairment
February 28, 2023Business Services
Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, …
Johnson & Johnson’s Janssen-Cilag unit gets disappointing ‘restricted’ label for PARP drug in EU
February 28, 2023Medical Communications
Johnson & Johnson (J&J)’s Janssen-Cilag unit has announced that its fixed-dose combination drug Akeega has been recommended for approval by …
Moderna to pay $400m to US government over new COVID-19 vaccine license
February 28, 2023Sales and Marketing
Moderna, a leader in the development of COVID-19 vaccines, announced that it has paid the National Institute of Allergy and …
CSL receives positive results from rare disease drug phase 3 trial
February 28, 2023Research and Development
Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …
MHRA’s authority restored following Northern Ireland Brexit deal
February 28, 2023Medical Communications
The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …
Rare and orphan disease expert Terebellum launches market access guide
February 28, 2023Business Services
Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …
Rare disease community call for their unified voice to be heard in the fight for equitable care
February 28, 2023Business Services
Reading, 28th February 2023.
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)
February 27, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
Almirall opens the doors of its R&D centre to the biotech ZeClinics
February 27, 2023Business Services
BARCELONA, Spain. February 27th 2023 – Almirall, a global biopharmaceutical company focused on skin health, today announced an agreement with …
HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China
February 27, 2023Business Services
Hong Kong, Shanghai & Florham Park, NJ — Monday, February 27, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM, HKEX:13) today announces …
CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System
February 27, 2023Business Services
Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems …
Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment
February 27, 2023Business Services
Cambridge, UK, 27 February 2023: Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced …
FDA sued by US states over abortion pill access
February 27, 2023Medical Communications
Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …
Causeway Therapeutics raises £8.75m for tennis elbow research
February 27, 2023Medical Communications
University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international …
AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohn’s disease
February 27, 2023Medical Communications
AbbVie has announced that it has received positive feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) …
Merck to appeal EU rejection of COVID-19 drug
February 27, 2023Medical Communications
Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …
Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzelura™) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents
February 24, 2023Business Services
WILMINGTON, Del. – February 24, 2023 – Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …
Janssen Receives Positive CHMP Opinion for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer
February 24, 2023Business Services
BEERSE, Belgium, 24 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for …
Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space
February 24, 2023Business Services
24th February 2023 – Automata, a leading automation company powering life science labs to fully automate their workflows, today launches
Latest content
FibroFind appoints Lee Borthwick as CEO
